THERMO FISHER SCIENTIFIC INC. Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Thermo Fisher Scientific Inc. quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Thermo Fisher Scientific Inc. Goodwill for the quarter ending September 28, 2024 was $46.7B, a 7.21% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $46.7B +$3.14B +7.21% Sep 28, 2024 10-Q 2024-11-01
Q2 2024 $43.8B +$570M +1.32% Jun 29, 2024 10-Q 2024-08-02
Q1 2024 $43.8B +$703M +1.63% Mar 30, 2024 10-Q 2024-05-03
Q4 2023 $44B +$2.82B +6.86% Dec 31, 2023 10-Q 2024-11-01
Q3 2023 $43.6B +$3.1B +7.64% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $43.3B +$2.21B +5.37% Jul 1, 2023 10-Q 2023-08-04
Q1 2023 $43.1B +$1.42B +3.4% Apr 1, 2023 10-Q 2023-05-05
Q4 2022 $41.2B -$728M -1.74% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $40.5B +$13.6B +50.5% Oct 1, 2022 10-Q 2022-11-04
Q2 2022 $41.1B +$14.2B +52.6% Jul 2, 2022 10-Q 2022-08-05
Q1 2022 $41.7B +$14.9B +55.5% Apr 2, 2022 10-Q 2022-05-06
Q4 2021 $41.9B +$15.9B +61% Dec 31, 2021 10-K 2024-02-22
Q3 2021 $26.9B +$1.13B +4.37% Oct 2, 2021 10-Q 2021-11-04
Q2 2021 $26.9B +$1.2B +4.69% Jul 3, 2021 10-Q 2021-08-06
Q1 2021 $26.8B +$1.21B +4.72% Apr 3, 2021 10-Q 2021-05-07
Q4 2020 $26B +$327M +1.27% Dec 31, 2020 10-K 2023-02-23
Q3 2020 $25.8B +$158M +0.62% Sep 26, 2020 10-Q 2020-10-30
Q2 2020 $25.7B -$57M -0.22% Jun 27, 2020 10-Q 2020-07-31
Q1 2020 $25.6B +$378M +1.5% Mar 28, 2020 10-Q 2020-05-01
Q4 2019 $25.7B +$367M +1.45% Dec 31, 2019 10-K 2022-02-24
Q3 2019 $25.6B +$482M +1.92% Sep 28, 2019 10-Q 2019-11-01
Q2 2019 $25.8B +$637M +2.54% Jun 29, 2019 10-Q 2019-08-02
Q1 2019 $25.2B -$126M -0.5% Mar 30, 2019 10-Q 2019-05-03
Q4 2018 $25.3B +$57M +0.23% Dec 31, 2018 10-K 2021-02-25
Q3 2018 $25.1B +$13.1M +0.05% Sep 29, 2018 10-Q 2018-11-02
Q2 2018 $25.1B +$3.27B +15% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $25.4B +$3.8B +17.6% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $25.3B +$3.96B +18.6% Dec 31, 2017 10-K 2020-02-26
Q3 2017 $25.1B +$3.55B +16.4% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $21.8B +$2.3B +11.8% Jul 1, 2017 10-Q 2017-08-04
Q1 2017 $21.6B +$1.93B +9.82% Apr 1, 2017 10-Q 2017-05-05
Q4 2016 $21.3B +$2.5B +13.3% Dec 31, 2016 10-K 2019-02-27
Q3 2016 $21.6B +$2.83B +15.1% Oct 1, 2016 10-Q 2016-11-04
Q2 2016 $19.5B +$740M +3.93% Jul 2, 2016 10-Q 2016-08-05
Q1 2016 $19.6B +$900M +4.8% Apr 2, 2016 10-Q 2016-05-06
Q4 2015 $18.8B -$14.6M -0.08% Dec 31, 2015 10-K 2018-02-28
Q3 2015 $18.7B -$301M -1.58% Sep 26, 2015 10-Q 2015-10-30
Q2 2015 $18.8B -$632M -3.25% Jun 27, 2015 10-Q 2015-07-31
Q1 2015 $18.7B -$797M -4.08% Mar 28, 2015 10-Q 2015-05-01
Q4 2014 $18.8B +$6.34B +50.7% Dec 31, 2014 8-K 2017-05-05
Q3 2014 $19B +$6.55B +52.4% Sep 27, 2014 10-Q 2014-10-31
Q2 2014 $19.4B +$7.05B +56.9% Jun 28, 2014 10-Q 2014-08-01
Q1 2014 $19.5B +$7.09B +56.9% Mar 29, 2014 10-Q 2014-05-02
Q4 2013 $12.5B +$28.8M +0.23% Dec 31, 2013 10-K 2016-02-25
Q3 2013 $12.5B +$61.5M +0.5% Sep 28, 2013 10-Q 2013-11-01
Q2 2013 $12.4B +$360M +3% Jun 29, 2013 10-Q 2013-08-02
Q1 2013 $12.4B +$360M +2.98% Mar 30, 2013 10-Q 2013-05-03
Q4 2012 $12.5B +$501M +4.19% Dec 31, 2012 10-K 2015-02-26
Q3 2012 $12.4B +$430M +3.58% Sep 29, 2012 10-Q 2012-11-02
Q2 2012 $12B +$1.66B +16% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 $12.1B +$3.05B +33.7% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $12B +$2.99B +33.3% Dec 31, 2011 8-K 2014-05-02
Q3 2011 $12B +$2.72B +29.3% Oct 1, 2011 10-Q 2011-11-04
Q2 2011 $10.4B +$1.27B +14% Jul 2, 2011 10-Q 2011-08-05
Q1 2011 $9.04B -$70.7M -0.78% Apr 2, 2011 10-Q 2011-05-06
Q4 2010 $8.98B Dec 31, 2010 8-K 2013-05-03
Q3 2010 $9.29B Oct 2, 2010 10-Q 2010-11-05
Q2 2010 $9.1B Jul 3, 2010 10-Q 2010-08-04
Q1 2010 $9.11B Apr 3, 2010 10-Q 2010-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.